Price Alert

YS Biopharma Co. Ltd. (YS)

NASDAQ: YS · Real-Time Price · USD

1.02

0.09 (9.68%)

At close: May 24, 2024, 10:00 PM

YS Biopharma Statistics

Share Statistics

YS Biopharma has 188.33M shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding	188.33M
Shares Change (YoY)	0%
Shares Change (QoQ)	0%
Owned by Institutions (%)	n/a
Shares Floating	17.1M
Failed to Deliver (FTD) Shares	540
FTD / Avg. Volume	0.41%

Short Selling Information

The latest short interest is 38.89K, so 0.02% of the outstanding shares have been sold short.

Short Interest	38.89K
Short % of Shares Out	0.02%
Short % of Float	0.03%
Short Ratio (days to cover)	1

Valuation Ratios

PE Ratio	0
Forward PE	1.01
PS Ratio	0
Forward PS	0.1
PB Ratio	0
P/FCF Ratio	0
PEG Ratio	0

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for YS Biopharma.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.83.

Current Ratio	1.02
Quick Ratio	0.75
Debt / Equity	0.83
Debt / EBITDA	-8.54
Debt / FCF	-2.98
Interest Coverage	-5.48

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$795.55K
Profits Per Employee	$-129.34K
Employee Count	773
Asset Turnover	0.45
Inventory Turnover	0.47

Taxes

Income Tax	-946.87K
Effective Tax Rate	0.94%

Stock Price Statistics

The stock price has increased by 42.66% in the last 52 weeks. The beta is 0.54, so YS Biopharma's price volatility has been higher than the market average.

Beta	0.54
52-Week Price Change	42.66%
50-Day Moving Average	0.84
200-Day Moving Average	0.67
Relative Strength Index (RSI)	41.08
Average Volume (20 Days)	130,559

Income Statement

In the last 12 months, YS Biopharma had revenue of 614.96M and earned -99.98M in profits. Earnings per share was -0.94.

Revenue	614.96M
Gross Profit	507.19M
Operating Income	-86.29M
Net Income	-99.98M
EBITDA	-48.54M
EBIT	-85.19M
Earnings Per Share (EPS)	-0.94

Full Income Statement

Balance Sheet

The company has 28.08M in cash and 414.4M in debt, giving a net cash position of -386.32M.

Cash & Cash Equivalents	28.08M
Total Debt	414.4M
Net Cash	-386.32M
Retained Earnings	-2.41B
Total Assets	1.51B
Working Capital	-56.24M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -120.98M and capital expenditures -17.86M, giving a free cash flow of -138.84M.

Operating Cash Flow	-120.98M
Capital Expenditures	-17.86M
Free Cash Flow	-138.84M
FCF Per Share	0

Full Cash Flow Statement

Margins

Gross margin is 82.47%, with operating and profit margins of -14.03% and -16.26%.

Gross Margin	82.47%
Operating Margin	-14.03%
Pretax Margin	-16.41%
Profit Margin	-16.26%
EBITDA Margin	-7.89%
EBIT Margin	-14.03%
FCF Margin	-22.58%

Dividends & Yields

YS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for YS.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	-2.16
Piotroski F-Score	4